Key result
Non-invasive ECG diagnostic patents surge since 2010, focusing on arrhythmia detection and risk assessment.
Why the study?
Accurate diagnosis of cardiovascular disease using electrocardiogram-based non-invasive systems is essential due to the multifactorial nature of CVD and the critical role of timely identification.
This review highlights 30 patents for non-invasive ECG-based systems aimed at improving the diagnosis and monitoring of cardiovascular diseases.
Novel algorithms may speed CVD diagnosis; leaves open whether they improve outcomes in practice.
Cardiovascular disease (CVD) is a global public health problem. It is a disease of multifactorial origin, and with this characteristic, having an accurate diagnosis of its incidence is a problem that health personnel face every day. That is why having all the indispensable tools to achieve optimal results is of utmost importance. Time is an essential factor when identifying heart problems, specialists look for and develop options to improve this aspect, which requires a thorough analysis of the patient, electrocardiograms being the factor standard for diagnosis and monitoring of patients. In this paper, we review patents and combined systems for the analysis of existing electrocardiogram signals, specific to cardiovascular diseases. All these methods and equipment have the purpose of giving an accurate diagnosis and a prediction of the presence of CVD in patients with positive risk factors. These are considered as the first diagnostic option, based on the guidelines already established in the field of preventive cardiology. The methodology consists of the searching of specific electrocardiography and cardiovascular disease subjects, taking as a reference the use of various patent databases. A total of 2634 patents were obtained in the consulted databases. Of that total, only 30 patents that met all the previous criteria were considered; furthermore, a second in-depth review of their information was conducted. It is expected that studying and reviewing these patents will allow us to know the variety of tools available for the different pathologies that make up CVD, not only for its immediate diagnosis because, as mentioned, the time factor is decisive for the best forecast but also to allow us to follow up on all the cases that arise, being able to provide a better quality of life to patients with CVD or even being able to lead them to a full recovery.
No takes yet. Share an insight, caveat, or question.
Flores et al. (2022) conducted a review in Cardiovascular diseases (n=30). Non-invasive ECG-based systems and methods was evaluated. Non-invasive ECG-based systems and methods for diagnosing cardiovascular diseases have seen significant patent development since 2010, primarily focusing on signal analysis, arrhythmia detection, and multi-parameter risk assessment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: